Iv Phlebitis
Oct. 4, 2024
Phlebitis as a consequence of peripheral intravenous administration of cisatracurium besylate in critically ill patients | BMJ Case Reports Phlebitis - DocCheck IV Site Assessment - Peripheral Intravenous Access Iv Phlebitis